Taken together, these results suggest that various molecular mechanisms concur to MYC activity in O1 tumours: genomic alterations, hypomethylation and down-regulation of its silencers mir34b and mir34c through hypermethylation of their promoter region. Here, MIR34C is linked to neoplasm.